Browsing: Disease Area > Gastrointestinal
Discover the importance of a pharmacologic Polycomb signature in predicting the prognosis of breast and gastric cancer in this Short Communication article from Epigenomics.
A recent study published in JCO Precision Oncology provides new insights into the pathobiology of NF1 mutant GISTs. Demonstrating the potential of genomically driven precision oncology care in the implementation of personalized treatments and counselling for patients with GISTs.
Researchers have unearthed molecular changes along the digestive tract that could aid the development of targeted therapies.
Discover the highlights of the 26th World Congress of International Association of Surgeons Gastroenterologists and Oncologists in Seoul discussing the epidemiology and treatment of gallbladder tumors.
The expert speakers from our recent webinar on the links between diet and mouth and gastrointestinal cancers address further questions from our audience.
This article reviews yttrium-90 radioembolization of hepatocellular carcinoma from a clinical perspective, considering safety and efficacy, patient selection, and optimal assessment and management of patients.
How have transarterial therapies for hepatocellular carcinoma evolved over recent years? What impact have these changes had on patient outcomes? Read more in our partner journal Hepatic Oncology.
Selective Internal Radiation Therapy (SIRT) or transarterial radioembolisation (TARE) involves injection of 90Y-containing microspheres through the hepatic artery into liver…
A test measuring levels of particular chemicals in the breath demonstrated encouraging results for the detection of stomach and esophageal cancer in a large patient trial.